載入...
Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
BACKGROUND: The present study was aimed to evaluate the efficacy and safety of at least three cycles of Bevacizumab in combination with chemotherapy regimens, FOLFIRI or FOLFOX to treat liver metastatic colorectal cancer and improved response rates in these patients. MATERIALS AND METHODS: In this n...
Na minha lista:
| 發表在: | Adv Biomed Res |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medknow Publications & Media Pvt Ltd
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4770632/ https://ncbi.nlm.nih.gov/pubmed/26962512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.175243 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|